324 related articles for article (PubMed ID: 12116067)
21. Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement.
Nazir HF; AlFutaisi A; Zacharia M; Elshinawy M; Mevada ST; Alrawas A; Khater D; Jaju D; Wali Y
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28623857
[TBL] [Abstract][Full Text] [Related]
22. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.
Ichikawa M; Suzuki D; Inamoto J; Ohshima J; Cho Y; Saitoh S; Kaneda M; Iguchi A; Ariga T
J Pediatr Hematol Oncol; 2012 Apr; 34(3):239-41. PubMed ID: 22246157
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia.
Silverman JA; Reynolds L; Deitcher SR
J Clin Pharmacol; 2013 Nov; 53(11):1139-45. PubMed ID: 23907766
[TBL] [Abstract][Full Text] [Related]
24. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
Yasu T; Ohno N; Kawamata T; Kurokawa Y
Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
Thomas DA; Sarris AH; Cortes J; Faderl S; O'Brien S; Giles FJ; Garcia-Manero G; Rodriguez MA; Cabanillas F; Kantarjian H
Cancer; 2006 Jan; 106(1):120-7. PubMed ID: 16331634
[TBL] [Abstract][Full Text] [Related]
26. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
27. Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine.
Griffiths JD; Stark RJ; Ding JC; Cooper IA
Cancer Treat Rep; 1986 Apr; 70(4):519-21. PubMed ID: 3009012
[TBL] [Abstract][Full Text] [Related]
28. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
[TBL] [Abstract][Full Text] [Related]
29. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Hutchinson RJ; Ho R; Burnette WB; Wells E; Bridges C; Renbarger J
Cancer Nurs; 2013; 36(5):E49-60. PubMed ID: 23842524
[TBL] [Abstract][Full Text] [Related]
30. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
31. Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve.
Vainionpää L; Kovala T; Tolonen U; Lanning M
Pediatr Neurol; 1995 Nov; 13(4):314-8. PubMed ID: 8771166
[TBL] [Abstract][Full Text] [Related]
32. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
Jain S; Kapoor G
Pediatr Blood Cancer; 2010 May; 54(5):783. PubMed ID: 20205256
[No Abstract] [Full Text] [Related]
33. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.
Mokhtar GM; Shaaban SY; Elbarbary NS; Fayed WA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):594-600. PubMed ID: 20921909
[TBL] [Abstract][Full Text] [Related]
34. Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia.
van Schie RM; Brüggemann RJ; Hoogerbrugge PM; te Loo DM
J Antimicrob Chemother; 2011 Aug; 66(8):1853-6. PubMed ID: 21652620
[TBL] [Abstract][Full Text] [Related]
35. The Pharmacogenomics of Vincristine-Induced Neuropathy: On Pins and Needles.
Berg SL; Parsons DW
JAMA Oncol; 2015 Oct; 1(7):975-6. PubMed ID: 26181361
[No Abstract] [Full Text] [Related]
36. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
[TBL] [Abstract][Full Text] [Related]
37. Precision medicine to improve the risk and benefit of cancer care: genetic factors in vincristine-related neuropathy.
McLeod HL
JAMA; 2015 Feb; 313(8):803-4. PubMed ID: 25710656
[No Abstract] [Full Text] [Related]
38. Accidental administration of vincristine into the brachial artery.
Jackson N; Hassan NB
Clin Oncol (R Coll Radiol); 1997; 9(3):198. PubMed ID: 9269559
[No Abstract] [Full Text] [Related]
39. Acute onset flaccid quadriparesis in pediatric non-Hodgkin lymphoma: vincristine induced or Guillain-Barré syndrome?
Bahl A; Chakrabarty B; Gulati S; Raju KN; Raja A; Bakhshi S
Pediatr Blood Cancer; 2010 Dec; 55(6):1234-5. PubMed ID: 20544812
[TBL] [Abstract][Full Text] [Related]
40. Vincristine sulfate liposome injection: a guide to its use in refractory or relapsed acute lymphoblastic leukemia.
Harrison TS; Lyseng-Williamson KA
BioDrugs; 2013 Feb; 27(1):69-74. PubMed ID: 23329395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
